Jan 19,2022

Use of Retrospective Continuous Glucose Monitoring Data Is Underrated and Underused

This article presents a series of patient case examples that illustrate how the use of retrospective data enables to identify and effectively address patterns of problematic glycemia.

CLINICAL STUDY

#cgm

View Analyst & Ambassador Comments
Go to original news
Jan 19,2022

Development of a Novel Insulin Sensor for Clinical Decision-Making

Researchers carried out the development and optimization of a novel decentralized disposable insulin electrochemical sensor focusing on obtaining high analytical and operational performance toward achieving a true point-of-care insulin testing device for clinical on-site application.

CLINICAL STUDY

#cgm

View Analyst & Ambassador Comments
Go to original news
Jan 20,2022

Health2Sync Expands Product Offering In Chronic Disease Management With Real Word Data Integration And Analytics

Taiwan-based digital health startup Health2Sync makes further inroads in personalized chronic disease management with an expanded coverage of the patient journey with the latest version of its mobile application capturing continuous glucose monitoring (CGM) data to improve overall lifestyles.

PRODUCT

#dtx

#cgm

View Analyst & Ambassador Comments
Go to original news
Jan 20,2022

BeatO Wins The National Startup Awards 2021

BeatO won the National Startup Awards 2021 in the Healthcare category for bringing access to healthcare in India.

View Analyst & Ambassador Comments
Go to original news
Jan 23,2022

Sweetch Wins 2022 BIG Innovation Award

Sweetch, a digital therapeutics innovator and creator of the precision engagement platform for chronic conditions, today announced it has been named a winner in the 2022 BIG Innovation Awards healthcare category, presented by the Business Intelligence Group.

View Analyst & Ambassador Comments
Go to original news
Jan 25,2022

Veteran Sportscaster Mike Golic Interviews Former Athletes About Living with Diabetes to Encourage People to Create a Personalized “Playbook” for Wellness

LifeScan, a world leader in blood glucose monitoring, has teamed up with former professional football player and prolific sports commentator Mike Golic to launch Talking Type You, a new campaign designed to encourage open conversation among people with diabetes

View Analyst & Ambassador Comments
Go to original news
Jan 25,2022

Glytec And Nebraska Medicine Establish Strategic Partnership to Advance Patient Safety and Innovation Around Insulin Management

Glytec, the only provider of cloud-based insulin management software across the continuum of care, today announced a new strategic partnership with Nebraska Medicine to advance patient safety and innovation around insulin management.

COLLABORATION PARTNERSHIP

#institution

View Analyst & Ambassador Comments
Go to original news
Jan 26,2022

ABBOTT REPORTS STRONG FOURTH-QUARTER 2021 RESULTS; ISSUES 2022 FORECAST

Abbott (NYSE: ABT) today announced financial results for the fourth quarter and full year ended Dec. 31, 2021, and issued its financial outlook for 2022. In Diabetes Care, FreeStyle Libre® sales were $1.0 billion in the quarter, which represents sales growth of 35.4 percent on a reported basis and 36.0 percent on an organic basis.

View Analyst & Ambassador Comments
Go to original news
Jan 28,2022

Insulet Announces FDA Clearance of its Omnipod® 5 Automated Insulin Delivery System, First Tubeless System with Smartphone Control

Insulet Corporation (NASDAQ: PODD) (Insulet or the Company), the global leader in tubeless insulin pump technology with its Omnipod® brand of products, today announced it has received clearance from the U.S. Food and Drug Administration (FDA) for its Omnipod® 5 Automated Insulin Delivery System (Omnipod 5) for individuals aged six years and older with type 1 diabetes. Omnipod 5 is the first tubeless automated insulin delivery (AID) system that integrates with the Dexcom G6 Continuous Glucose Monitoring (CGM) System and a compatible smartphone to automatically adjust insulin and help protect against highs and lows.

REGULATORY FDA

#insulin pump

View Analyst & Ambassador Comments
Go to original news
Feb 28,2022

Rimidi to Showcase Continuous Glucose Monitor Integration with the EHR at ViVE, HIMSS 2022

Rimidi today announced that the company will showcase its latest medical device integrations – including its integration with Abbott’s FreeStyle Libre continuous glucose monitoring system – at ViVE and HIMSS 2022 this March.

CONFERENCES
View Analyst & Ambassador Comments
Go to original news
Subscribe to DIABETES